ArticleJournal of family & community medicine
Health-related quality of life and its determinants in patients with migraine relating to the coronavirus disease 2019 pandemic in the Eastern Province of Saudi Arabia.
Article in Journal of family & community medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMigraine is a neurological disorder associated with different levels of disability that can impact health-related quality of life (HRQoL). The management of this condition worsened with the challenges posed by the coronavirus disease 2019 (COVID-19) pandemic. This study sought to evaluate the effects of migraine on HRQoL and identify key factors contributing to these outcomes in migraineurs in relation to the COVID-19 pandemic. MATERIALS AND
methodsA cross-sectional study was carried out on 198 migraine patients between October 2022 and April 2023. HRQoL was assessed using the EQ-5D-5L comprising five domains. Data was collected by both face-to-face interviews and a self-administered online questionnaire. Categorical variables were described as frequencies and percentages while means with standard deviations or medians with interquartile ranges (IQRs) were computed for continuous variables. Chi-square test was used to assess associations of COVID-19 infection with migraine complications and HRQol.
resultsThe majority of the cohort were predominantly females (67.7%), university graduates (79.8%), and unemployed (63.3%). About 53% of migraineurs who reported no COVID-19 infection, indicated an increase in migraine attacks during the pandemic, whereas 51.9% of the participants who had COVID-19 reported an increase in attacks (P = 0.894). Migraineurs aged <30 years reported a significantly higher HRQoL score (median=0.94, IQR = 0.17, P < 0.001). Participants with higher income levels reported better HRQol (median: 0.89). Those with multi-comorbidities (median= 0.84 vs. 0.99, P < 0.05) showed significantly lower HRQoL.
conclusionStudy highlighted significant impact of COVID-19 on increasing frequency of migraine attacks in individuals infected with COVID-19, which in turn led to a decline in HRQol. Correlates of poor HRQoL included advancing age, low income, presence of multiple comorbidities, and unhealthy body mass index. An urgent intervention to improve the HRQol should be implemented after the pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.